@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAQbSfCVmhVjKKHc7iciee1pstSSiFvKsFkIM2sMeqF-Y> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAQbSfCVmhVjKKHc7iciee1pstSSiFvKsFkIM2sMeqF-Y#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix sdis: <http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-diseases/> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix mgi: <http://www.informatics.jax.org/marker/MGI:> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 geneProductOf: mgi:97275;
    a Protein: .
  
  sub:_2 occursIn: mesh:D018482, species:10090;
    rdf:object sub:_1;
    rdf:predicate belv:increases;
    rdf:subject sdis:mechanical%20stress;
    a rdf:Statement .
  
  sub:assertion rdfs:label "path(SDIS:\"mechanical stress\") -> p(MGI:Myod1)" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_4;
    pav:version "1.4" .
  
  sub:_3 prov:value "A later peak of follistatin expression (2- to 3-fold increase) was noted starting from day 10 and persisted until day 30. To deter- mine whether follistatin activation coincides with the appearance of activated satellite cells, we analyzed the expression of several markers of satellite cells activation. Msx1 is transcribed in quiescent satellite cells and its expression is extinguished upon cell activation (Cor- nelison et al., 2000). On the other hand, only activated satellite cells express MyoD (Cornelison and Wold, 1997), Numb (Conboy and Rando, 2002), and, at later stages, myogenin (Cornelison and Wold, 1997). Twelve hours after muscle injury, we noted that expression of Msx1 was reduced while MyoD and Numb expression increased.";
    prov:wasQuotedFrom pubmed:15130492 .
  
  sub:_4 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:15130492;
    prov:wasDerivedFrom beldoc:, sub:_3 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:30:23.218+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}